MEDx (Suzhou) Translational Medicine Co., Ltd

Jiangsu,China

home product company profile Certifications Exhibition contact

MEDx (Suzhou) Translational Medicine Co., Ltd

Jiangsu,China

favorite supplier

verified

Ordinary Member

home product company profile Certifications contact

MEDx (Suzhou) Translational Medicine Co., Ltd

favorite supplier

verified

Ordinary Member

MEDx (Suzhou) Translational Medicine Co., Ltd

Jiangsu,China

Scan QR code

Access to mobile station

home product company profile Certifications contact

Compare

Clear All

Microsatellite Instability (MSI) Dx Analysis Test

FOB Price : Get a Price/Quote

Min.Order : 1 Piece(s)

Certification : CFDA,CE

Brand Name : MEDx

Payment Terms : T/T

contact now Video Conference

favorite

Add to Compare

product information

brand name : MEDx
certification : CFDA,CE
min.order : 1 Piece(s)
warranty : 1 Year
payment terms : T/T
Packaging : /
Specification : 85*75*75mm
place of origin : Jiangsu

product description

This product is used for the in vitro qualitative detection of Microsatellite Instability (MSI) status in neutral formalin-fixed, paraffin-embedded (FFPE) colorectal cancer tissues for the adjuvant diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) and for the concomitant diagnosis of PD-1/PD-L1 immunosuppressive drugs.
This kit uses multiplex fluorescence PCR-capillary electrophoresis to qualitatively detect microsatellite instability in human cancer tissue samples and their paired normal control samples (paracancerous normal tissue samples or blood samples). The kit mainly involves nine microsatellite sites, BAT25, BAT26, BAT52, BAT56, BAT59, BAT60, MONO27, NR21, NR24.